OncoTargets and Therapy (Jul 2023)
LncRNA MCM3AP-AS1 Promotes Cell Proliferation and Invasion Through Regulating miR-543-3p/SLC39A10/PTEN Axis in Prostate Cancer [Retraction]
Abstract
Jia Z, Li W, Bian P, Liu H, Pan D, Dou Z. Onco Targets Ther. 2020;13:9365–9376. We, the Editor and Publisher of OncoTargets and Therapy are retracting the published article. Since publication, concerns have been raised about the duplication of images in this article with those from other unrelated articles. Specifically, The image from Figure 2D, LNCaP, Si-MCM3AP-AS1, has been duplicated with the image from Figure 2C, sh-linc01711, from Xu M, Liu T, Dong F, Meng L, Ling A, Liu S. Exosomal lncRNA LINC01711 facilitates metastasis of esophageal squamous cell carcinoma via the miR-326/FSCN1 axis. Aging (Albany NY). 2021;13:19776–19788. https://doi.org/10.18632/aging.203389. The image from Figure 4B, PC-3, Si-NC, has been duplicated with the image from Figure 2B, SK-MES-1, miR-130a-5p inhibitor, from Ma F, Xie Y, Lei Y, et al. The microRNA-130a-5p/RUNX2/STK32A network modulates tumor invasive and metastatic potential in non-small cell lung cancer. BMC Cancer. 2020;20:580. https://doi.org/10.1186/s12885-020-07056-0. When approached for an explanation, the authors have been unable to address the concerns raised and have not been able to provide sufficient original data from their study. As verifying the validity of published work is core to the integrity of the scholarly record, we are therefore retracting the article. The authors listed in this publication have been informed. We have been informed in our decision-making by our editorial policies and the COPE guidelines. The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.
